MotherToBaby is the Leading National Resource on Exposures during Pregnancy and Breastfeeding BRENTWOOD, TN – The non-profit Organization of Teratology Information Specialists (OTIS), which provides the MotherToBaby free service, receives new funding aimed at enhancing partnerships to address birth defects, infant disorders and related conditions, and the health of pregnant and postpartum people. The grant is supported by the Centers for Disease Control and Prevention (CDC). The funding is …
Press Releases: birth defects
World Birth Defects Day March 3 Free Events
World Birth Defects Day is March 3 and MotherToBaby is a proud partner in two of the events scheduled for that day - the Facebook Live Event at 1p ET about the COVID-19 vaccine in pregnancy and breastfeeding featuring our own Sonja Rasmussen, MD, Lorrie Harris-Sagaribay, MPH, Kirstie Perrotta, MPH and our Past President Robert Felix. In addition, a #WorldBDDay Twitter chat is scheduled and, alongside the non-profit Family Voices, our Al Romeo, RN, PhD, will present a free webinar on lead …
World-Wide Twitter Chat Set for March 3 #WorldBDDay
On March 3, join MotherToBaby, March of Dimes and dozens of organizations around the world for a World Birth Defects Day Twitter Chat. Ask questions about birth defects, pregnancy health and more. Include the hashtag #WorldBDDay in every tweet to take part! …
MotherToBaby Hosts First-Ever World Birth Defects Day Facebook and Instagram Live Event March 3
Join MotherToBaby and partner organizations around the world for a special World Birth Defects Day Facebook and Instagram Live Chat March 3 at 10a PT/1p ET. How to participate: Follow @MotherToBaby on Facebook or @mothertobabyotis on Instagram (or both). You might get a notification from Facebook or Instagram that the MotherToBaby page you follow is going live at the live broadcast start time. Alternatively, just go to MotherToBaby’s profile on either Facebook or Instagram at the broadcast …
Study Suggests Adalimumab Exposure in Pregnancy Does Not Increase Birth Defects Risk
602 Pregnancies Examined by the Non-Profit Organization of Teratology Information Specialists LA JOLLA, CA –A new study conducted by birth defects experts from the Organization of Teratology Information Specialists (OTIS) suggests adalimumab use in pregnancy was not associated with an increased risk for adverse outcomes examined, such as major structural birth defects, spontaneous abortion and preterm delivery. The findings were published today in the Public Library of Science (PLOS) One …
